@article{TLCR33443,
author = {Yiwei Huang and Xiaodong Yang and Fenghao Sun and Tao Lu and Guoshu Bi and Jiaqi Liang and Qihai Sui and Cheng Zhan and Yu Shi and Qun Wang},
title = {Prognostic effects of glycometabolism changes in lung adenocarcinoma: a prospective observational study},
journal = {Translational Lung Cancer Research},
volume = {8},
number = {6},
year = {2019},
keywords = {},
abstract = {Background: Changes in glycometabolism of cancer cells provides cancer cells with growth advantages, which are also of great value in the prognosis prediction of the patients with lung adenocarcinoma. However, currently available studies are controversial.
Methods: We successively collected 100 paired surgical specimens from patients with lung adenocarcinoma. The content of glycometabolic intermediates in tissues was tested by liquid chromatography-mass spectrometry. Follow-up was conducted every 6 months for patients enrolled in this study.
Results: There were significant differences in the contents of six intermediates, including glucose (P},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/33443}
}